The cells lining our blood vessels have different jobs in different organs. A new human cell atlas shows that aging leaves both shared and locally distinct molecular patterns in this lining, offering a more detailed starting point for understanding vascular decline.
Sarah Dobner, Lisa Kleissl, Fanni Tóth and colleagues published the Human Aging Endothelial Cell Atlas study in Nature Aging on October 23, 2026. The resource contains 375,829 endothelial cell profiles drawn from 34 studies and 290 donors across 12 tissues. It is a molecular research resource, with supporting laboratory experiments, rather than a clinical treatment trial.
The living lining of blood vessels
Endothelial cells form the inner surface of vessels. They help control blood flow, the movement of substances between blood and tissue, clotting and the formation of new vessels. Their local specializations matter: vessels supporting the brain’s protective barrier face different demands from vessels involved in kidney filtration.
This makes vascular aging more complicated than one universal change in one type of cell. An apparent aging signal could reflect a shared biological process, a particular organ’s environment, or a specific part of the vascular network.
How single-cell analysis builds an atlas
Single-cell RNA sequencing measures RNA messages in individual cells. These messages provide clues to which genes are active. Reading cells separately can reveal differences that would be blurred if an entire tissue were averaged together. Some source studies examined cell nuclei instead of whole cells.
The researchers brought existing datasets into a common analytical framework, removed low-quality or contaminating profiles, and identified endothelial subtypes. They included healthy or nondiseased tissue from adipose tissue, brain, breast, heart, intestine, kidney, liver, lung, muscle, ovary, skin and uterus.
For aging comparisons, they grouped donors using tissue-specific age thresholds and checked results with a second approach comparing people aged 50 or younger with those aged 60 or older. They combined cell counts at the donor level for statistical comparisons, helping avoid treating thousands of cells from one person as thousands of independent people.
Shared inflammation, with different vascular patterns
Across tissues, older endothelial cells showed more activity in inflammation-related and senescence-associated gene programs. Angiogenesis-related programs, involved in making new blood vessels, tended to decline. The decrease in angiogenic signatures was particularly pronounced in venous endothelial cells.
Gene activity is a clue to function, rather than a direct measurement of vessel repair in a patient. The findings suggest questions about why regeneration becomes less effective with age; they do not quantify a person’s ability to heal.
The atlas also retained strong tissue-specific patterns. Capillary cells were particularly specialized by organ. Age-associated changes in the extracellular matrix, the material surrounding cells, were prominent in liver, lung, skin and adipose tissue. Different vascular subtypes showed additional distinctions, including clotting-related signatures in older arterial cells.
How cells sense their surroundings
The team found changes in mechanotransduction, the process by which cells respond to physical forces. Think of it as a cell translating pressure, stretch or properties of its surroundings into biological instructions.
In human skin samples, the researchers confirmed greater nuclear localization of YAP, a protein involved in this signaling, in older endothelial cells. Its presence in the nucleus suggests increased activity. Whether that activity contributes to damage or represents an attempt to compensate remains unresolved.
Senescence needs more than one marker
Cellular senescence involves persistent changes such as withdrawal from division and altered signaling. The team identified a gene-expression program associated with p21, a protein linked to cell-cycle control, and investigated it using cultured human cells and mouse models of accelerated vascular aging.
One candidate, MAFF, was consistently enriched across several models. Increasing MAFF in cultured endothelial cells induced senescence-associated features. This experiment provides evidence within a laboratory system, rather than demonstrating a therapeutic target that is safe or effective in people.
The authors caution that p21 is not exclusive to senescent cells. It can also participate in other cellular responses, including transient vascular remodeling. An atlas signal cannot automatically be translated into a count of harmful cells that should be removed.
A research map with boundaries
The large cell count should not obscure the smaller and uneven donor groups. People aged 80 and older were underrepresented. Age distributions differed by tissue, and the source datasets did not consistently report lifestyle, medication, illness or other potential confounders. The study was not powered to resolve sex differences.
Technical differences between studies, including how tissues were processed and whether cells or nuclei were sequenced, may also affect results. Combining datasets helps address such variation but cannot eliminate it. These comparisons across different people do not track every donor’s vessels as they age.
Our interpretation is that the atlas can help researchers choose more precise hypotheses, compare healthy aging with disease, and test whether a proposed intervention affects the relevant cells and pathways. Demonstrating reversal would require additional functional experiments and, ultimately, appropriate human studies. The atlas itself does not show that vascular aging can be reversed or that lifespan can be extended.
How this differs from the MTR4 study
Our October 21 report on MTR4 examined experiments manipulating an RNA-regulating protein in model systems. This study instead provides a broad human reference map across tissues and vascular subtypes, then follows up selected signals experimentally. It is a distinct contribution to understanding where and how vascular aging varies.
Original research
Dobner S, Kleissl L, Tóth F et al. Uncovering the transcriptional hallmarks of endothelial cell aging via integrated single-cell analysis. Nature Aging, October 23, 2026. doi:10.1038/s43587-026-01247-3. Full open-access original paper reviewed. Research classification: Human Molecular Research, with supporting cultured-cell and mouse experiments.
Featured image: AI-generated conceptual scientific illustration for The Lifespan Brief; not microscopy or atlas data.